| Results summary | View all lists in L2L MDB | View all genes in G01A.profile.u50 |
|
Up-regulated at 6 hr following treatment of peripheral blood mononuclear cells (PBMC) with BAY 50-4798, an IL-2 receptor agonist. enrichment: 5.96-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 209921_AT | SLC7A11 | T | P | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | |||||||||
| 217678_AT | SLC7A11 | T | P | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | |||||||||
| 202284_S_AT | CDKN1A | G | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | ||||||||||
| 207528_S_AT | SLC7A11 | T | P | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | |||||||||
| 202672_S_AT | ATF3 | E | R | activating transcription factor 3 | |||||||||
| 202644_S_AT | TNFAIP3 | G | P | S | tumor necrosis factor, alpha-induced protein 3 | ||||||||
| 206026_S_AT | TNFAIP6 | X | C | S | tumor necrosis factor, alpha-induced protein 6 | ||||||||